{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:39:51Z","timestamp":1791567591218,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the contribution of dyslipidemia to the high and rising burden of arteriosclerotic cardiovascular disease (CVD) in Sub-Saharan Africa; the condition is under-diagnosed, under-treated, and under-described. The objective of this study was to explore the prevalence of dyslipidemias, estimate a 10-year cardiovascular disease risk and associated factors in adults (\u2265\u200935 to\u2009\u2264\u200985\u00a0years) living in Asmara, Eritrea. This population-based cross-sectional study was conducted among individuals without overt CVDs in Asmara, Eritrea, from October 2020 to November 2020. After stratified multistage sampling, a total of 386 (144 (37%) males and 242 (63%) females, mean age\u2009\u00b1\u2009SD, 52.17\u2009\u00b1\u200913.29\u00a0years) respondents were randomly selected. The WHO NCD STEPS instrument version 3.1 questionnaire was used to collect data. Information on socio-demographic variables was collected via interviews by trained data collectors. Measurements\/or analyses including anthropometric, lipid panel, fasting plasma glucose, and blood pressure were also undertaken. Finally, data was analyzed by using Statistical Package for Social Sciences version 26.0 for Windows (SPSS Inc., Chicago, IL, USA). All <jats:italic>p<\/jats:italic>-values were 2-sided and the level of significance was set at <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 for all analyses. The frequency of dyslipidemia in this population was disproportionately high (87.4%) with the worst affected subgroup in the 51\u201360 age band. Further, 98% of the study participants were not aware of their diagnosis. In terms of individual lipid markers, the proportions were as follows: low HDL-C (55.2%); high TC (49.7%); high LDL (44.8%); high TG (38.1%). The mean\u2009\u00b1\u2009SD, for HDL-C, TC, LDL-C, non-HDL-C, and TG were 45.28\u2009\u00b1\u20099.60; 205.24\u2009\u00b1\u200945.77; 130.77\u2009\u00b1\u200936.15; 160.22\u2009\u00b1\u200942.09 and 144.5\u2009\u00b1\u200961.26\u00a0mg\/dL, respectively. Regarding NCEP ATP III risk criteria, 17.6%, 19.4%, 16.3%, 19.7%, and 54.7% were in high or very high-risk categories for TC, Non-HDL-C, TG, LDL-C, and HDL-C, respectively. Among all respondents, 59.6% had mixed dyslipidemias with TC\u2009+\u2009TG\u2009+\u2009LDL-C dominating. In addition, 27.3%, 28.04%, 23.0%, and 8.6% had abnormalities in 1, 2, 3 and 4 lipid abnormalities, respectively. Multivariate logistic regression modeling suggested that dyslipidemia was lower in subjects who were employed (aOR 0.48, 95% CI 0.24\u20130.97, <jats:italic>p<\/jats:italic>\u2009=\u20090.015); self-employed (aOR 0.41, 95% CI 0.17\u20131.00, <jats:italic>p<\/jats:italic>\u2009=\u20090.018); and married (aOR 2.35, 95% CI 1.19\u20134.66, <jats:italic>p<\/jats:italic>\u2009=\u20090.009). A higher likelihood of dyslipidemia was also associated with increasing DBP (aOR 1.04\u00a0mmHg (1.00\u20131.09, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and increasing FPG (aOR 1.02 per 1\u00a0mg\/dL, 95% CI 1.00\u20131.05, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). Separately, Framingham CVD Risk score estimates suggested that 12.7% and 2.8% were at 10\u00a0years CVD high risk or very high-risk strata. High frequency of poor lipid health may be a prominent contributor to the high burden of atherosclerotic CVDs\u2014related mortality and morbidity in Asmara, Eritrea. Consequently, efforts directed at early detection, and evidence-based interventions are warranted. The low awareness rate also points at education within the population as a possible intervention pathway.<\/jats:p>","DOI":"10.1038\/s41598-022-09446-9","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:04:13Z","timestamp":1648893853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A community based cross sectional study on the prevalence of dyslipidemias and 10\u00a0years cardiovascular risk scores in adults in Asmara, Eritrea"],"prefix":"10.1038","volume":"12","author":[{"given":"Oliver Okoth","family":"Achila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahom","family":"Fessahye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Tekle","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naemi Tesfamariam","family":"Habtemikael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wintana Yebio","family":"Werke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femal Tesfazghi","family":"Zemichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haben Negash","family":"Leghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Amanuel","family":"Weldegegish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegay Habteab","family":"Tekeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyob Yohannes","family":"Garoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"9446_CR1","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specify mortality for 264 causes of death, 1980\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1151\u2013210 (2017)."},{"key":"9446_CR2","unstructured":"GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and health life expectancy (HALE) for 195 countries and territories, 1990\u20132016: A systematic analysis for the Global. Lancet 390, 1260\u2013344 (2017)."},{"key":"9446_CR3","doi-asserted-by":"crossref","unstructured":"GBD 2019 Risk Factors Collaborators, Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223\u201349 (2020).","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"9446_CR4","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1016\/S2214-109X(18)30275-4","volume":"6","author":"JJ Noubiap","year":"2018","unstructured":"Noubiap, J. J. et al. Prevalence of dyslipidaemia among adults in Africa: A systematic review and meta-analysis. Lancet Glob. Heal. 6, e998-1007 (2018).","journal-title":"Lancet Glob. Heal."},{"key":"9446_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/STROKEAHA.118.020783","volume":"49","author":"FS Sarfo","year":"2018","unstructured":"Sarfo, F. S. et al. Stroke among young West Africans: Evidence from the SIREN, large multisite case\u2013control study. Stroke 49, 1116\u20131122 (2018).","journal-title":"Stroke"},{"key":"9446_CR6","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.5830\/CVJA-2015-038","volume":"26","author":"MO Owolabi","year":"2015","unstructured":"Owolabi, M. O. et al. The burden of stroke in Africa: A glance at the present and a glimpse into the future. Cardiovasc. J. Afr. 26, S27-38 (2015).","journal-title":"Cardiovasc. J. Afr."},{"issue":"1","key":"9446_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5334\/gh.403)","volume":"15","author":"MF Yuyun","year":"2020","unstructured":"Yuyun, M. F., Sliwa, K., Kengne, A. P., Mocumbi, A. O. & Bukhman, G. Cardiovascular diseases in Sub-Saharan Africa compared to high-income countries: An epidemiological perspective. Glob. Heart 15(1), 15. https:\/\/doi.org\/10.5334\/gh.403) (2020).","journal-title":"Glob. Heart"},{"key":"9446_CR8","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1161\/CIRCULATIONAHA.105.563452","volume":"112","author":"K Steyn","year":"2005","unstructured":"Steyn, K. et al. Risk factors associated with myocardial infarction in Africa: The INTERHEART Africa study. Circulation 112, 3554\u20133561 (2005).","journal-title":"Circulation"},{"key":"9446_CR9","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, \u201cExecutive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol. J. Am. Med. Assoc. 285, 2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"9446_CR10","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2013","unstructured":"Stone, N. J. et al. ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 63, 2889\u20132934 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9446_CR11","doi-asserted-by":"crossref","unstructured":"Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr. Pr. 23, 1\u201387.","DOI":"10.4158\/EP171764.APPGL"},{"key":"9446_CR12","unstructured":"WHO. Preventing Chronic Diseases: A vital investment. (2005)."},{"key":"9446_CR13","unstructured":"WHO. World Health Organization Global Health Observatory Map Gallery."},{"key":"9446_CR14","unstructured":"WHO. British Hearth Foundation Statistics website, Prevalence estimates of overweight and obesity for 2002, and projections for 2005 and 2010, by sex, adults aged 15and over, the world (2009)."},{"key":"9446_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-016-0550-5","author":"C Franchi","year":"2016","unstructured":"Franchi, C. et al. Emergency department visits in older people: Pattern of use, contributing factors, geographical differences and outcomes. Aging Clin. Exp. Res. https:\/\/doi.org\/10.1007\/s40520-016-0550-5 (2016).","journal-title":"Aging Clin. Exp. Res."},{"key":"9446_CR16","doi-asserted-by":"crossref","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representation). Eur. Heart J. 37, 2315\u20132381 (2016).","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"9446_CR17","unstructured":"Naing, L. & Winn T., Practical issues in calculating the sample size for prevalence studies. Arch. Orofac. Sci. 1, 9\u201314 (2006)."},{"key":"9446_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6155304","volume":"1","author":"OO Achila","year":"2021","unstructured":"Achila, O. O. et al. Dyslipidemia and associated risk factors in the elderly population in Asmara, Eritrea: Results from a community-based cross-sectional study. J. Lipids. 1, 1\u20131. https:\/\/doi.org\/10.1155\/2021\/6155304 (2021).","journal-title":"J. Lipids."},{"key":"9446_CR19","unstructured":"WHO. WHO STEPwise approach to surveillance (STEPS)."},{"key":"9446_CR20","unstructured":"International Diabetes Federation (IDF). Diabetes Atlas. (2016)."},{"key":"9446_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08037059943973313","volume":"8","author":"M Alderman","year":"1999","unstructured":"Alderman, M. et al. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Blood Press 8, 9\u201343 (1999).","journal-title":"Blood Press"},{"key":"9446_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee. JAMA 311, 507\u2013520 (2014).","journal-title":"JAMA"},{"key":"9446_CR23","doi-asserted-by":"publisher","first-page":"e0187347","DOI":"10.1371\/journal.pone.0187347","volume":"12","author":"S Reiger","year":"2017","unstructured":"Reiger, S. et al. Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study. PLoS One 12, e0187347 (2017).","journal-title":"PLoS One"},{"key":"9446_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12916-020-01648-0","volume":"18","author":"ALG Soares","year":"2020","unstructured":"Soares, A. L. G. et al. A comparison of the associations between adiposity and lipids in Malawi and United Kingdom. BMC Med. 18, 181. https:\/\/doi.org\/10.1186\/s12916-020-01648-0 (2020).","journal-title":"BMC Med."},{"key":"9446_CR25","doi-asserted-by":"publisher","first-page":"e007954","DOI":"10.1136\/bmjopen-2015-007954","volume":"5","author":"S Asghari","year":"2015","unstructured":"Asghari, S. et al. Single and mixed dyslipidaemia in Canadian primary care settings: Findings from the Canadian primary care sentinel surveillance network database. BMJ Open 5, e007954 (2015).","journal-title":"BMJ Open"},{"key":"9446_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12944-018-0731-7","volume":"17","author":"S Kutkiene","year":"2018","unstructured":"Kutkiene, S. et al. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: A cross-sectional cohort study. Lipids Health Dis. 17, 88 (2018).","journal-title":"Lipids Health Dis."},{"key":"9446_CR27","doi-asserted-by":"publisher","first-page":"e22579","DOI":"10.1002\/jcla.22579","volume":"32","author":"S Darroudi","year":"2018","unstructured":"Darroudi, S. et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J. Clin. Lab. Anal. 32, e22579 (2018).","journal-title":"J. Clin. Lab. Anal."},{"key":"9446_CR28","doi-asserted-by":"publisher","first-page":"e102830","DOI":"10.1371\/journal.pone.0102830","volume":"9","author":"AA Alsheikh-Ali","year":"2014","unstructured":"Alsheikh-Ali, A. A. et al. Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study. PLoS One 9, e102830 (2014).","journal-title":"PLoS One"},{"key":"9446_CR29","doi-asserted-by":"crossref","unstructured":"Reiger S, Jardim TV, Abrahams-Gessel S, Crowther NJ, Wade A, Gomez-Olive FX, et al. Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study. PLoS One 12 (2017).","DOI":"10.1371\/journal.pone.0187347"},{"key":"9446_CR30","doi-asserted-by":"crossref","unstructured":"Mahmoud I, S. N. Dyslipidemia prevalence and associated risk factors in the United Arab Emirates: a population based study. BMJ Open e031969 (2019).","DOI":"10.1136\/bmjopen-2019-031969"},{"key":"9446_CR31","doi-asserted-by":"crossref","unstructured":"Gebreegziabiher G, Belachew T, Mehari K, T. D. Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLoS One 16, e02243103 (2021).","DOI":"10.1371\/journal.pone.0243103"},{"key":"9446_CR32","doi-asserted-by":"crossref","unstructured":"Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, et al. Prevalence of dyslipidemia in urban and rural India: The ICMR\u2013INDIAB Study. PLoS One 9, e96808 (2014).","DOI":"10.1371\/journal.pone.0096808"},{"key":"9446_CR33","doi-asserted-by":"crossref","unstructured":"Karaye KM, H. A. Dyslipidaemia in patients with established cardiovascular disease in sub-Saharan Africa: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 21, 682\u2013691 (2014).","DOI":"10.1177\/2047487312460018"},{"issue":"4","key":"9446_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jacl.2012.05.002","volume":"6","author":"PP T\u00f3th","year":"2012","unstructured":"T\u00f3th, P. P., Potter, D. & Ming, E. E. Prevalence of lipid abnormalities in the united states: the national health and nutrition examination survey 2003\u20132006. J. Clin. Lipidol. 6(4), 325\u2013330 (2012).","journal-title":"J. Clin. Lipidol."},{"key":"9446_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jacl.2012.05.002","volume":"6","author":"PP Toth","year":"2012","unstructured":"Toth, P. P. & Potter, D. Prevalence of lipid abnormalities in the United States: The national health and nutrition examination survey 2003\u20132006. J. Clin. Lipidol. 6, 325\u2013330 (2012).","journal-title":"J. Clin. Lipidol."},{"issue":"5","key":"9446_CR36","doi-asserted-by":"publisher","first-page":"e005222","DOI":"10.1136\/bmjgh-2021-005222","volume":"6","author":"R Greiner","year":"2021","unstructured":"Greiner, R. et al. Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies. BMJ Global Health 6(5), e005222 (2021).","journal-title":"BMJ Global Health"},{"key":"9446_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","volume":"372","author":"MJ McQueen","year":"2008","unstructured":"McQueen, M. J. et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case\u2013control study. Lancet 372, 224\u2013233 (2008).","journal-title":"Lancet"},{"key":"9446_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.puhe.2019.09.002","volume":"178","author":"D Adeloye","year":"2020","unstructured":"Adeloye, D. et al. Prevalence of hypercholesterolemia in Nigeria: A systematic review and meta-analysis. Public Health 178, 167\u2013178 (2020).","journal-title":"Public Health"},{"key":"9446_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0140-6736(08)60417-1","volume":"371","author":"K Sliwa","year":"2008","unstructured":"Sliwa, K. et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study. Lancet 371, 915\u201322 (2008).","journal-title":"Lancet"},{"key":"9446_CR40","doi-asserted-by":"publisher","first-page":"e031969","DOI":"10.1136\/bmjopen-2019-031969","volume":"9","author":"I Mahmoud","year":"2019","unstructured":"Mahmoud, I. Dyslipidaemia prevalence and associated risk factors in the United Arab Emirates: A population based study. BMJ Open 9, e031969 (2019).","journal-title":"BMJ Open"},{"key":"9446_CR41","doi-asserted-by":"publisher","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","volume":"9","author":"SR Joshi","year":"2014","unstructured":"Joshi, S. R. et al. Prevalence of dyslipidemia in urban and rural India: The ICMR\u2013INDIAB study. PLoS One 9, e96808 (2014).","journal-title":"PLoS One"},{"key":"9446_CR42","doi-asserted-by":"crossref","unstructured":"Sumner AE, Zhou J, Doumatey A, Imoisili OE, Amoah A, et al. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with Metabolic Syndrome: Implications for cardiovascular disease prevention. CVD Prev. Control 5, 75\u201380 (2010).","DOI":"10.1016\/j.cvdpc.2010.07.003"},{"key":"9446_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","volume":"380","author":"BF Voight","year":"2012","unstructured":"Voight, B. F. et al. Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. Lancet 380, 572\u2013580 (2012).","journal-title":"Lancet"},{"key":"9446_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/HJR.0b013e32833ba61e","volume":"18","author":"M Eriksson","year":"2011","unstructured":"Eriksson, M. et al. Blood lipids in 75,048 type 2 diabetic patients: A population-based survey from the Swedish National diabetes register. Eur. J. Cardiovasc. Prev. Rehab. 18, 97\u2013105 (2011).","journal-title":"Eur. J. Cardiovasc. Prev. Rehab."},{"key":"9446_CR45","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1172\/JCI117603","volume":"94","author":"JC Cohen","year":"1994","unstructured":"Cohen, J. C., Wang, Z., Grundy, S. M. & Stoesz, M. R. Variation at the hepatic lipase and apolipoprotein AI\/CIII\/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94, 2377\u20132384 (1994).","journal-title":"J. Clin. Invest."},{"key":"9446_CR46","doi-asserted-by":"publisher","first-page":"e012616","DOI":"10.1371\/journal.pone.0126166","volume":"10","author":"G Asiki","year":"2015","unstructured":"Asiki, G. et al. Prevalence of dyslipidaemia and associated risk factors in a rural population in south-western Uganda: A community based survey. PLoS One 10, e012616 (2015).","journal-title":"PLoS One"},{"key":"9446_CR47","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit, W. et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J. Lipid Res. 45, 1169\u20131196 (2004).","journal-title":"J. Lipid Res."},{"key":"9446_CR48","doi-asserted-by":"crossref","unstructured":"Dannenberg AL, Keller JB, Wilson PWF, C. W. Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. Am. J. Epidemiol. 129, 76\u201387 (1989).","DOI":"10.1093\/oxfordjournals.aje.a115126"},{"key":"9446_CR49","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.1986.03380200061022","volume":"256","author":"J Stamler","year":"1986","unstructured":"Stamler, J. & Wentworth, D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256, 2823\u20138 (1986).","journal-title":"JAMA"},{"key":"9446_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman, M. J. et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. Eur. Heart J. 32, 1345\u2013136 (2011).","journal-title":"Eur. Heart J."},{"key":"9446_CR51","doi-asserted-by":"publisher","first-page":"e0194819","DOI":"10.1371\/journal.pone.0194819","volume":"13","author":"YF Gebreyesus","year":"2015","unstructured":"Gebreyesus, Y. F. et al. Prevalence of high blood pressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey. PLoS One 13, e0194819 (2015).","journal-title":"PLoS One"},{"key":"9446_CR52","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard, B. G. Triglycerides and cardiovascular disease. Lancet 384, 626\u2013635 (2014).","journal-title":"Lancet"},{"key":"9446_CR53","doi-asserted-by":"crossref","unstructured":"Achila, O.O., Ghebretinsae, M., Kidane, A., Simon, M. & Makonen, S. Factors associated with poor glycemic and lipid levels in ambulatory diabetes mellitus type 2 patients in Asmara, Eritrea: A cross-sectional study. J. Diabetes Res. 2020 (2020).","DOI":"10.1155\/2020\/5901569"},{"key":"9446_CR54","doi-asserted-by":"crossref","unstructured":"Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, G. E. No Title. Vasc. Health Risk Manag. 247\u2013254 (2012).","DOI":"10.2147\/VHRM.S27668"},{"key":"9446_CR55","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1161\/hc5001.100624","volume":"104","author":"CM Ballantyne","year":"2001","unstructured":"Ballantyne, C. M. et al. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 104, 3046\u20133951 (2001).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09446-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:17:42Z","timestamp":1669339062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09446-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9446"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09446-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5567"}}